Projects per year
Organization profile
The research focus of Neuroscience Center (NC) is on translational brain plasticity. We carry out research relevant for the human brain both in health and disease, and during development and aging, by applying versatile approaches and modern technology platforms.
NC aims at making fundamental discoveries about brain functions and especially translate research findings into improvements in the treatment, prevention and diagnosis of psychiatric and neurological disorders. The research in NC spans across several scales from stem cell research and molecular neuroscience to systems and cognitive neuroscience in both animal and human models.
Neuroscience Center is one of the three operational units units at HiLIFE, the Helsinki Institute of Life Science.
Fields of Science
- 3112 Neurosciences
- 118 Biological sciences
- 1182 Biochemistry, cell and molecular biology
- 1184 Genetics, developmental biology, physiology
- 515 Psychology
International and National Collaboration
Profiles
-
Tommi Ala-Kurikka
- Molecular and Integrative Biosciences Research Programme - Grant-funded researcher
- Laboratory of Neurobiology
- Doctoral Programme Brain & Mind
Person: Visiting scholar, Doctoral Researcher, UH
-
Alexandra Andersson
- Neuroscience Center - Doctoral Researcher
- Doctoral Programme Brain & Mind
Person: U1 Research and teaching staff, Doctoral Researcher
-
Liliia Andriichuk
- Neuroscience Center - Doctoral Researcher
- Doctoral Programme in Biomedicine
Person: U1 Research and teaching staff, Doctoral Researcher
-
Raz Balin
- Neuroscience Center - Doctoral Researcher
- Doctoral Programme Brain & Mind
Person: U1 Research and teaching staff, Doctoral Researcher
Research Units
-
Brain development and neuropsychiatric disorders
Organisational unit: Research group
-
Laboratory of Neurobiology
Neuroscience Center, Molecular and Integrative Biosciences Research Programme
Organisational unit: Research group
-
Synaptic Plasticity and Development
Neuroscience Center, Molecular and Integrative Biosciences Research Programme
Organisational unit: Research group
Equipment
-
Mouse Behavioural Phenotyping Facility
Vootele Voikar (Manager)
Neuroscience CenterFacility/equipment: Equipment
-
-
-
-
Early Life Stress in First Stages of Neurodevelopment
01/11/2021 → 01/11/2024
Project: Research project
-
Systems-level neuronal basis of short-term and working memory
01/09/2019 → 31/08/2023
Project: Research project
-
-
-
-
Abnormal brain development of monoamine oxidase mutant zebrafish and impaired social interaction of heterozygous fish
Baronio, D., Chen, Y-C. & Panula, P., Mar 2022, In: Disease Models & Mechanisms. 15, 3, 14 p., 049133.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
A novel variant in SMG9 causes intellectual disability, confirming a role for nonsense-mediated decay components in neurocognitive development
Rahikkala, E., Urpa, L., Ghimire, B., Topa, H., Kurki, M., Koskela, M., Airavaara, M., Hamalainen, E., Pylkas, K., Korkko, J., Savolainen, H., Suoranta, A., Bertoli-Avella, A., Rolfs, A., Mattila, P., Daly, M., Palotie, A., Pietiläinen, O., Moilanen, J. & Kuismin, O., 28 Jan 2022, (E-pub ahead of print) In: European Journal of Human Genetics. 9 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access -
Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro
Fred, S. M., Kuivanen, S., Ugurlu, H., Casarotto, P. C., Levanov, L., Saksela, K., Vapalahti, O. & Castren, E., 19 Jan 2022, In: Frontiers in Pharmacology. 12, 15 p., 755600.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Cell Culture Media, Unlike the Presence of Insulin, Affect alpha-Synuclein Aggregation in Dopaminergic Neurons
Hlushchuk, I., Barut, J., Airavaara, M., Luk, K., Domanskyi, A. & Chmielarz, P., Apr 2022, In: Biomolecules. 12, 4, 15 p., 563.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Clinical and societal burden of incident major depressive disorder: A population-wide cohort study in Stockholm
Lundberg, J., Cars, T., Lööv, S-Å., Söderling, J., Tiihonen, J., Leval, A., Gannedahl, A., Björkholm, C., Själin, M. & Hellner, C., 2 Mar 2022, (E-pub ahead of print) In: Acta Psychiatrica Scandinavica. 13 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
Activities
-
BDNF receptor TrkB as a direct target for antidepressant drugs
Eero Castrén (Speaker)
22 Sep 2021Activity: Talk or presentation types › Invited talk
-
Neuronal plasticity, neurotrophin signaling and the antidepressant effect
Eero Castrén (Speaker)
8 Apr 2021Activity: Talk or presentation types › Invited talk
-
Neuronal plasticity and neurotrophin signaling as the common mechanism for antidepressant effect
Eero Castrén (Speaker)
7 Oct 2021Activity: Talk or presentation types › Invited talk
-
European College of Neuropsychopharmacology (ECNP), (External organisation)
Eero Castrén (Member)
2021 → …Activity: Membership types › Membership or other role in national/international committee, council, board
-
Neuronal plasticity and neurotrophin signaling as the common mechanism for antidepressant effect
Eero Castrén (Speaker)
10 Sep 2021Activity: Talk or presentation types › Invited talk
Prizes
-
-
-
Best Journal Article Prize 2017 for Early State Researchers
Spoljaric, Albert (Recipient), 4 Apr 2018
Prize: Prizes and awards
-
Best Master's thesis in 2009 by the Faculty of Biological and Environmental Sciences
Helmy, M. (Recipient), 2009
Prize: Prizes and awards
-
Best Poster Award FGSN/B&M student symposium 2013
Antila, H. (Recipient), 6 Sep 2013
Prize: Prizes and awards
Press / Media
-
Herantis Pharma Oyj: Herantis Pharma Announces Paper in Journal Genes on biomarker -driven approaches in Parkinson’s Disease (Cision)
30/09/2021
2 items of Media coverage
Press/Media: Press / Media
-
Herantis Pharma Announces Paper in Journal Genes on biomarker -driven approaches in Parkinson's Disease
30/09/2021
2 items of Media coverage
Press/Media: Press / Media
-
-Herantis Pharma Announces Poster and Presentation at MDS Virtual Congress 2021
20/09/2021
1 item of Media coverage
Press/Media: Press / Media
-
Herantis Pharma Oyj: Herantis Pharma Announces Poster and Presentation at MDS Virtual Congress 2021 (Cision)
17/09/2021
1 item of Media coverage
Press/Media: Press / Media
-
Herantis Pharma Announces Poster and Presentation at MDS Virtual Congress 2021
17/09/2021
3 items of Media coverage
Press/Media: Press / Media